Unknown

Dataset Information

0

Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.


ABSTRACT: This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.

SUBMITTER: Hurt AC 

PROVIDER: S-EPMC4280814 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.

Hurt Aeron C AC   Hui David S DS   Hay Alan A   Hayden Frederick G FG  

Influenza and other respiratory viruses 20141115 1


This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus  ...[more]

Similar Datasets

| S-EPMC7132446 | biostudies-literature
| S-EPMC7132401 | biostudies-literature
| S-EPMC6297936 | biostudies-other
| S-EPMC2649748 | biostudies-other
| S-EPMC5841193 | biostudies-literature
| S-EPMC6965566 | biostudies-literature
| S-EPMC4666198 | biostudies-literature
| S-EPMC8206461 | biostudies-literature
| S-EPMC5478801 | biostudies-literature
| S-EPMC8578530 | biostudies-literature